Creating fear: the 'doping deaths', risk communication and the anti-doping campaign

被引:15
|
作者
Lopez, Bernat [1 ]
机构
[1] Univ Rovira & Virgili, Dept Commun Studies, Tarragona, Spain
关键词
anti-doping; EPO; growth hormone; mass media; propaganda; risk communication;
D O I
10.1080/19406940.2013.773359
中图分类号
F [经济];
学科分类号
02 ;
摘要
One of the most recurrent topics in the anti-doping literature is the one about 'doping deaths', or the more encompassing 'doping health hazards'. This is hardly surprising since one of the main justifications for the current anti-doping policies is that they have been set up to protect athletes' health. This article critically examines the rational and empirical basis for the claims concerning famous 'doping deaths', such as those of Arthur Linton, Tom Simpson or the Dutch and Belgian cyclists who allegedly died due to erythropoietin (EPO) abuse in the late 1980s and early 1990s. It is argued that these claims have become common sense or naturalized knowledge through repetition and lack of critical confrontation, and it is demonstrated that they are untenable under close scrutiny. It is therefore concluded that they are perfect examples of a discourse of fear, or risk communication at the service of a social control and surveillance agenda, namely, the one embodied by anti-doping.
引用
收藏
页码:213 / 225
页数:13
相关论文
共 50 条
  • [41] Anti-doping and Pharmaceutical Sciences Foreword
    Shimba, Shigeki
    Nakajima, Rie
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (02): : 101 - 102
  • [42] Impact of anti-doping education and doping control experience on anti-doping knowledge in Japanese university athletes: a cross-sectional study
    Yuka Murofushi
    Yujiro Kawata
    Akari Kamimura
    Masataka Hirosawa
    Nobuto Shibata
    Substance Abuse Treatment, Prevention, and Policy, 13
  • [43] The analytical challenges of anti-doping analysis
    Harrison, Christopher R.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (30) : 9615 - 9616
  • [44] Ethical considerations in anti-doping analysis
    Murray, Thomas H.
    BIOANALYSIS, 2012, 4 (13) : 1537 - 1539
  • [45] Athlete Performance Monitoring in Anti-Doping
    Hopker, James
    Schumacher, Yorck O.
    Fedoruk, Matthew
    Morkeberg, Jakob
    Bermon, Stephane
    Iljukov, Sergei
    Aikin, Reid
    Sottas, Pierre-Edouard
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [46] Anti-doping control in equestrian sports
    Gogny, Marc
    Pouliquen, Herve
    POINT VETERINAIRE, 2009, 40 (294): : 70 - 70
  • [47] Anti-doping Activities by Hospital Pharmacists
    Muraki, Yuko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2022, 142 (02): : 109 - 113
  • [48] Outlook for the future of the anti-doping movement
    Mueller, David
    GERMAN JOURNAL OF EXERCISE AND SPORT RESEARCH, 2012, 42 (03) : 202 - 213
  • [49] Insights in Anti-doping Sciences: 2021
    Faiss, Raphael
    FRONTIERS IN SPORTS AND ACTIVE LIVING, 2023, 5
  • [50] More money - better anti-doping?
    Martensen, Carsten Kraushaar
    Moller, Verner
    DRUGS-EDUCATION PREVENTION AND POLICY, 2017, 24 (03) : 286 - 294